Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children

Summary

The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.

Timeline

Start

2017-01-03

Primary completion

2017-07-21

Completion

2017-07-21

Drugs

Indications